Last reviewed · How we verify
NCT03851484: SenST
Sensory Symptoms in Tourette Syndrome
trial in Tourette Syndrome in 214 participants. Currently enrolling.
31 March 2028
Quick facts
| Lead sponsor | Vanderbilt University Medical Center |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 214 |
| Start date | 17 April 2019 |
| Primary completion | 31 March 2028 |
| Estimated completion | 31 December 2028 |
| Sites | 2 locations across United States |
Conditions studied
- Tourette Syndrome — all drugs for Tourette Syndrome →
Sponsor
Vanderbilt University Medical Center
Who can join
18 and older, any sex, with Tourette Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with tics will be asked to complete a series of validated questionnaires (in electronic and/or paper format) regarding symptoms and conditions often associated with Tourette syndrome, including premonitory urges, sensory experiences, inattention, obsessive-compulsive tendencies, anxiety, and depression. Participants will also be asked to complete a quality of life assessment. This series of questionnaires will be administered annually.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03851484
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tourette Syndrome
Currently open trials in the same condition.
- NCT07203469 — Where Wild Things Grow: Nature- and Activity-based Group Interventions for Neurodivergent Children and Youth · NA · recruiting
- NCT06679790 — Trajectories of Change in Tourette Syndrome · NA · recruiting
- NCT06678737 — CBIT+TMS R33 Phase · Phase 2 · recruiting
- NCT06909656 — Multimodal Electrophysiological Study of Cortico-subcortical Biomarkers of Tics in Tourette Syndrome · NA · recruiting
- NCT06785532 — Effect of RNS in Treatment-refractory Tourette's Syndrome · NA · recruiting
Other Vanderbilt University Medical Center trials
Trials by the same sponsor.
- NCT07005037 — Swallowing Impairments in ICU Survivors and Community-Dwelling Adults · not yet recruiting
- NCT07527273 — Cognitive Enhancement in Recurrent Depression (The COG-D-R Study) · NA · not yet recruiting
- NCT07295288 — Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis · Phase 4 · not yet recruiting
- NCT07431541 — Topical Carboxytherapy Paste Following Microneedling · Phase 1, PHASE2 · not yet recruiting
- NCT07224711 — The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03851484 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vanderbilt University Medical Center
- Last refreshed: 13 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03851484.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing